节点文献
Na[125I]标记6-酮-PGF1α和血栓素B2
Na [125I] -labelled 6-keto-PGF1a and Thromboxane B2
【摘要】 <正> 前列环素(FGI2,其稳定代谢产物6-keto-PGF1α)和血栓素A2(TXA2,其稳定代谢产物TXB2)为花生四烯酸代谢途径的两个重要产物,它们的生理活性恰巧相反,前者抑制血小板聚集和扩张血管,后者诱导血小板聚集和收缩血管。二者平衡如果失调,可能导致某些疾病的发生。为了推广敏感的、特异的测定6-keto-PGF1α和TXB2放射免疫法,我们用Na[125I]成功地标记了6-keto-PGF1α和TXB2。
【Abstract】 Na [125I] -labeled antigens with high specific activity were prepared by radioiodination of 6-Keto-PGF1a or thromboxaneB2-tyrosine methyl ester conjugate followed by purification with thin-layer Chromatography. Using Na [125I] 6-Keto-PGF1a-TME or Na[125I] TXB2-TME as labeled antigens to develop radioimmunoassay which offer some advantages such as high specific activity, low bound-to-total ratio in the absence of antibody, simple handly and particularly economical when a lot of simples assayed
- 【文献出处】 中国医学科学院学报 ,Acta Academiae Medicinae Sinicae , 编辑部邮箱 ,1986年01期
- 【被引频次】4
- 【下载频次】12